These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 3535004)
1. Double-blind crossover study of ranitidine and placebo in gastro-oesophageal reflux disease. Johansson KE; Boeryd B; Johansson K; Tibbling L Scand J Gastroenterol; 1986 Sep; 21(7):769-78. PubMed ID: 3535004 [TBL] [Abstract][Full Text] [Related]
2. Gastric secretion and reflux pattern in reflux oesophagitis before and during ranitidine treatment. Johansson KE; Tibbling L Scand J Gastroenterol; 1986 May; 21(4):487-92. PubMed ID: 3523741 [TBL] [Abstract][Full Text] [Related]
3. Effects of ranitidine and cisapride on acid reflux and oesophageal motility in patients with reflux oesophagitis: a 24 hour ambulatory combined pH and manometry study. Inauen W; Emde C; Weber B; Armstrong D; Bettschen HU; Huber T; Scheurer U; Blum AL; Halter F; Merki HS Gut; 1993 Aug; 34(8):1025-31. PubMed ID: 8174947 [TBL] [Abstract][Full Text] [Related]
4. Oesophagitis, signs of reflux, and gastric acid secretion in patients with symptoms of gastro-oesophageal reflux disease. Johansson KE; Ask P; Boeryd B; Fransson SG; Tibbling L Scand J Gastroenterol; 1986 Sep; 21(7):837-47. PubMed ID: 3775250 [TBL] [Abstract][Full Text] [Related]
5. Effects of ranitidine treatment on patients with asthma and a history of gastro-oesophageal reflux: a double blind crossover study. Ekström T; Lindgren BR; Tibbling L Thorax; 1989 Jan; 44(1):19-23. PubMed ID: 2648642 [TBL] [Abstract][Full Text] [Related]
6. Gastro-oesophageal reflux disease in The Netherlands. Results of a multicentre pH study. Smout AJ; Geus WP; Mulder PG; Stockbrügger RW; Lamers CB Scand J Gastroenterol Suppl; 1996; 218():10-5. PubMed ID: 8865445 [TBL] [Abstract][Full Text] [Related]
7. Maintenance treatment with ranitidine compared with fundoplication in gastro-oesophageal reflux disease. Johansson KE; Tibbling L Scand J Gastroenterol; 1986 Sep; 21(7):779-88. PubMed ID: 3535005 [TBL] [Abstract][Full Text] [Related]
8. Cisapride and ranitidine in the treatment of gastro-oesophageal reflux disease--a comparative randomized double-blind trial. Arvanitakis C; Nikopoułos A; Theoharidis A; Giannoulis E; Vagios I; Anthopoulou H; Michailidis D; Tourkantonis A Aliment Pharmacol Ther; 1993 Dec; 7(6):635-41. PubMed ID: 8161670 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of omeprazole in lower grades of gastro-oesophageal reflux disease. Havelund T; Laursen LS; Lauritsen K Scand J Gastroenterol Suppl; 1994; 201():69-73. PubMed ID: 8047827 [TBL] [Abstract][Full Text] [Related]
10. Gastro-oesophageal reflux during 3 months of therapy with ranitidine in reflux oesophagitis. Hatlebakk JG; Berstad A Scand J Gastroenterol; 1996 Oct; 31(10):954-8. PubMed ID: 8898414 [TBL] [Abstract][Full Text] [Related]
11. Oral ranitidine and duration of gastric pH >4.0 in infants with persisting reflux symptoms. Salvatore S; Hauser B; Salvatoni A; Vandenplas Y Acta Paediatr; 2006 Feb; 95(2):176-81. PubMed ID: 16449023 [TBL] [Abstract][Full Text] [Related]
12. Investigation of ranitidine 150 mg bd or 300 mg bd in the treatment of reflux disease. Schaub N; Meyrick Thomas J; Misiewicz JJ; Lovell D; Trotman IF Hepatogastroenterology; 1986 Oct; 33(5):208-13. PubMed ID: 3804176 [TBL] [Abstract][Full Text] [Related]
13. Ranitidine therapy for gastroesophageal reflux disease. Results of a large double-blind trial. Sontag S; Robinson M; McCallum RW; Barwick KW; Nardi R Arch Intern Med; 1987 Aug; 147(8):1485-91. PubMed ID: 3307670 [TBL] [Abstract][Full Text] [Related]
15. Short-term treatment of reflux oesophagitis with ranitidine 300 mg nocte. Italian multicentre study. Bovero E; Cheli R; Barbara L; Baldi F; Boero A; Mura GC; Camarri E; Corradini P; Dobrilla G; Piazzi L Hepatogastroenterology; 1987 Aug; 34(4):155-9. PubMed ID: 3311954 [TBL] [Abstract][Full Text] [Related]
16. Long-term ranitidine in progressive systemic sclerosis (scleroderma) with gastroesophageal reflux. Hendel L; Aggestrup S; Stentoft P Scand J Gastroenterol; 1986 Sep; 21(7):799-805. PubMed ID: 3535006 [TBL] [Abstract][Full Text] [Related]
17. Symptomatic gastro-oesophageal reflux disease: double blind controlled study of intermittent treatment with omeprazole or ranitidine. The European Study Group. Bardhan KD; Müller-Lissner S; Bigard MA; Bianchi Porro G; Ponce J; Hosie J; Scott M; Weir DG; Gillon KR; Peacock RA; Fulton C BMJ; 1999 Feb; 318(7182):502-7. PubMed ID: 10024259 [TBL] [Abstract][Full Text] [Related]
18. Ranitidine in reflux oesophagitis. A double-blind placebo-controlled study. Hine KR; Holmes GK; Melikian V; Lucey M; Fairclough PD Digestion; 1984; 29(2):119-23. PubMed ID: 6329862 [TBL] [Abstract][Full Text] [Related]
19. Effects of ranitidine, given t.d.s., on intragastric and oesophageal pH in patients with gastrooesophageal reflux. Russell J; Orr WC; Wilson T; Finn AL Aliment Pharmacol Ther; 1991 Dec; 5(6):621-30. PubMed ID: 1782305 [TBL] [Abstract][Full Text] [Related]
20. Ambulatory pH monitoring of gastro-oesophageal reflux in "morning dipper" asthmatics. Nagel RA; Brown P; Perks WH; Wilson RS; Kerr GD BMJ; 1988 Nov; 297(6660):1371-3. PubMed ID: 3146369 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]